Skip to main content
Top
Gepubliceerd in: Neuropraxis 2/2018

15-02-2018 | Artikel

Dilemma’s rondom prenatale screening op downsyndroom

Auteurs: Neeltje M. T. H. Crombag, Linda Martin, Janneke T. Gitsels

Gepubliceerd in: Neuropraxis | Uitgave 2/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Prenatale screening op congenitale afwijkingen is in Nederland vanaf 2007 beschikbaar voor elke zwangere vrouw. Ontwikkelingen en medische vernieuwingen in dit domein volgen elkaar snel op en leiden onder meer tot steeds betere testkarakteristieken. Ondanks dat blijven de dilemma’s voor aanstaande ouders onveranderd complex. Vergeleken met omliggende landen wordt in Nederland relatief weinig gebruikgemaakt van prenatale screening op downsyndroom. In dit artikel beschrijven we kort de geschiedenis van prenatale screening op downsyndroom in Nederland en de achtergrond van het relatief lage deelnamepercentage. Vervolgens beschrijven we welke factoren een rol spelen bij gebruik van prenatale screening op diverse niveaus (overheid, organisatie, maatschappij, zorgverlening), met welke dilemma’s aanstaande ouders te maken krijgen en hoe ouders hierin worden begeleid. Tot slot reflecteren we op de rol van prenatale screening op aangeboren afwijkingen in de Nederlandse gezondheidzorg en maatschappij.
Voetnoten
1
Ten tijde van het onderzoek heette het screeningsprogramma ‘Screening op downsyndroom’, maar werd ook op edwards- en patausyndroom getest. Voor deelnemers lag de nadruk op downsyndroom voor de ethische afwegingen om eventueel aan de combinatietest deel te nemen. Voor de ethische dilemma’s zullen we ons in het artikel dan ook richten op de screening op downsyndroom.
 
Literatuur
1.
go back to reference Hewison J. Psychological aspects of individualized choice and reproductive autonomy in prenatal screening. Bioethics. 2015;29(1):9–18. CrossRefPubMed Hewison J. Psychological aspects of individualized choice and reproductive autonomy in prenatal screening. Bioethics. 2015;29(1):9–18. CrossRefPubMed
2.
go back to reference Jong A de, Dondorp WJ, Die-Smulders CE de, Frints SG, Wert GM de. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet. 2010;18:272–7. CrossRefPubMed Jong A de, Dondorp WJ, Die-Smulders CE de, Frints SG, Wert GM de. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet. 2010;18:272–7. CrossRefPubMed
3.
go back to reference Jong A de, Dondorp WJ, Frints SGM, Die-Smulders CEM de, Wert GM de. Advances in prenatal screening: the ethical dimension. Nat Rev Genet. 2011;12(9):657–63. CrossRefPubMed Jong A de, Dondorp WJ, Frints SGM, Die-Smulders CEM de, Wert GM de. Advances in prenatal screening: the ethical dimension. Nat Rev Genet. 2011;12(9):657–63. CrossRefPubMed
4.
go back to reference Gezondheidsraad. Wet bevolkingsonderzoek: prenatale screening op downsyndroom en neuralebuisdefecten. publicatienr. 2007/05WBO. Den Haag: Gezondheidsraad; 2007. Gezondheidsraad. Wet bevolkingsonderzoek: prenatale screening op downsyndroom en neuralebuisdefecten. publicatienr. 2007/05WBO. Den Haag: Gezondheidsraad; 2007.
5.
go back to reference Gezondheidsraad. Prenatale screening. publicatienr. 2016/19. Den Haag: Gezondheidsraad; 2016. Gezondheidsraad. Prenatale screening. publicatienr. 2016/19. Den Haag: Gezondheidsraad; 2016.
6.
go back to reference Schendel RV van, Page-Christiaens GC, Beulen L, Bilardo CM, Boer MA de, Coumans ABC, et al. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women’s perspectives. Prenat Diagn. 2016;36(12):1091–8. CrossRefPubMedPubMedCentral Schendel RV van, Page-Christiaens GC, Beulen L, Bilardo CM, Boer MA de, Coumans ABC, et al. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women’s perspectives. Prenat Diagn. 2016;36(12):1091–8. CrossRefPubMedPubMedCentral
7.
go back to reference Oepkes D, Page-Christiaens GC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, et al. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact. Prenat Diagn. 2016;36(12):1083–90. CrossRefPubMedPubMedCentral Oepkes D, Page-Christiaens GC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, et al. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact. Prenat Diagn. 2016;36(12):1083–90. CrossRefPubMedPubMedCentral
9.
go back to reference Commissie Screening erfelijke en aangeboren aandoeningen. Genetische screening. Publicatienr. 1994/22. Den Haag: Gezondheidsraad; 1994. Commissie Screening erfelijke en aangeboren aandoeningen. Genetische screening. Publicatienr. 1994/22. Den Haag: Gezondheidsraad; 1994.
10.
go back to reference Tweede kamer. Brief d.d. 15 september 2005 van de staatssecretaris van Volksgezondheid Welzijn en Sport aan de voorzitter van de Tweede Kamer der Staten-Generaal. Den Haag: Ministerie van VWS; 2005. Tweede kamer. Brief d.d. 15 september 2005 van de staatssecretaris van Volksgezondheid Welzijn en Sport aan de voorzitter van de Tweede Kamer der Staten-Generaal. Den Haag: Ministerie van VWS; 2005.
11.
go back to reference Crombag NM, Vellinga YE, Kluijfhout SA, Bryant LD, Ward PA, Iedema-Kuiper R, et al. Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res. 2014;14(1):437–25. CrossRefPubMedPubMedCentral Crombag NM, Vellinga YE, Kluijfhout SA, Bryant LD, Ward PA, Iedema-Kuiper R, et al. Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res. 2014;14(1):437–25. CrossRefPubMedPubMedCentral
12.
go back to reference Ekelund CK, Andersen HJ, Christensen J, Ersbak V, Farlie R, Henriques C, et al. Down’s syndrome risk assessment in Denmark—secondary publication. Ugeskr Laeg. 2010;172(23):1759–61. PubMed Ekelund CK, Andersen HJ, Christensen J, Ersbak V, Farlie R, Henriques C, et al. Down’s syndrome risk assessment in Denmark—secondary publication. Ugeskr Laeg. 2010;172(23):1759–61. PubMed
13.
go back to reference Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A. Danish fetal medicine research group. Impact of a new national screening policy for down’s syndrome in Denmark: population based cohort study. BMJ. 2008;337:a2547. CrossRefPubMedPubMedCentral Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A. Danish fetal medicine research group. Impact of a new national screening policy for down’s syndrome in Denmark: population based cohort study. BMJ. 2008;337:a2547. CrossRefPubMedPubMedCentral
14.
go back to reference Ekelund CK, Petersen OB, Skibsted L, Kjaergaard S, Vogel I, Tabor A. Danish fetal medicine research group. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. Ultrasound Obstet Gynecol. 2011;38(2):140–4. CrossRefPubMed Ekelund CK, Petersen OB, Skibsted L, Kjaergaard S, Vogel I, Tabor A. Danish fetal medicine research group. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. Ultrasound Obstet Gynecol. 2011;38(2):140–4. CrossRefPubMed
15.
go back to reference NHS fetal anomaly screening programme. NHS fetal anomaly screening programme annual report 2011–2012. Publication no. 2011/12. Exeter: UK National Screening Committee Programmes Directorate; 2012. NHS fetal anomaly screening programme. NHS fetal anomaly screening programme annual report 2011–2012. Publication no. 2011/12. Exeter: UK National Screening Committee Programmes Directorate; 2012.
16.
go back to reference Siljee JE, Schielen PCJI. Kwaliteitscontrole parameters van de Nederlandse down syndroom screening laboratoria 2011. Projectnummer 230083003/2012. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu te Bilthoven; 2013. Siljee JE, Schielen PCJI. Kwaliteitscontrole parameters van de Nederlandse down syndroom screening laboratoria 2011. Projectnummer 230083003/2012. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu te Bilthoven; 2013.
17.
go back to reference Crombag NM, Boeije H, Iedema-Kuiper R, Schielen PC, Visser GH, Bensing JM. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study. BMC Pregnancy Childbirth. 2016;16(1):121. CrossRefPubMedPubMedCentral Crombag NM, Boeije H, Iedema-Kuiper R, Schielen PC, Visser GH, Bensing JM. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study. BMC Pregnancy Childbirth. 2016;16(1):121. CrossRefPubMedPubMedCentral
18.
go back to reference Etchegary H, Potter B, Howley H, Cappelli M, Coyle D, Graham I, et al. The influence of experiential knowledge on prenatal screening and testing decisions. Genet Test. 2008;12(1):115–24. CrossRefPubMed Etchegary H, Potter B, Howley H, Cappelli M, Coyle D, Graham I, et al. The influence of experiential knowledge on prenatal screening and testing decisions. Genet Test. 2008;12(1):115–24. CrossRefPubMed
19.
go back to reference Garcia E, Timmermans DRM, Leeuwen E van. The impact of ethical beliefs on decisions about prenatal screening tests: searching for justification. Soc Sci Med. 2008;66(3):753–64. CrossRefPubMed Garcia E, Timmermans DRM, Leeuwen E van. The impact of ethical beliefs on decisions about prenatal screening tests: searching for justification. Soc Sci Med. 2008;66(3):753–64. CrossRefPubMed
20.
go back to reference Berg M van den, Timmermans DR, Kleinveld JH, Garcia E, Vugt JM van, Wal G van der. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women’s reasons. Prenat Diagn. 2005;25(1):84–90. CrossRefPubMed Berg M van den, Timmermans DR, Kleinveld JH, Garcia E, Vugt JM van, Wal G van der. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women’s reasons. Prenat Diagn. 2005;25(1):84–90. CrossRefPubMed
21.
go back to reference Gottfredsdottir H, Bjornsdottir K, Sandall J. How do prospective parents who decline prenatal screening account for their decision? A qualitative study. Soc Sci Med. 2009;69(2):274–7. CrossRefPubMed Gottfredsdottir H, Bjornsdottir K, Sandall J. How do prospective parents who decline prenatal screening account for their decision? A qualitative study. Soc Sci Med. 2009;69(2):274–7. CrossRefPubMed
22.
go back to reference Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess. 2004;8(33):1–109. CrossRef Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess. 2004;8(33):1–109. CrossRef
23.
go back to reference Gitsels-van der Wal JT, Manniën J, Ghaly MM, Verhoeven PS, Hutton EK, Reinders HS. The role of religion in decision-making on antenatal screening of congenital anomalies: a qualitative study amongst Muslim Turkish origin immigrants. Midwifery. 2014;30(3):297–302. CrossRefPubMed Gitsels-van der Wal JT, Manniën J, Ghaly MM, Verhoeven PS, Hutton EK, Reinders HS. The role of religion in decision-making on antenatal screening of congenital anomalies: a qualitative study amongst Muslim Turkish origin immigrants. Midwifery. 2014;30(3):297–302. CrossRefPubMed
24.
go back to reference Gitsels-van der Wal JT, Martin L, Manniën J, Verhoeven P, Hutton EK, Reinders HS. A qualitative study on how Muslim women of Moroccan descent approach antenatal anomaly screening. Midwifery. 2015;31(3):e43–9. CrossRefPubMed Gitsels-van der Wal JT, Martin L, Manniën J, Verhoeven P, Hutton EK, Reinders HS. A qualitative study on how Muslim women of Moroccan descent approach antenatal anomaly screening. Midwifery. 2015;31(3):e43–9. CrossRefPubMed
25.
go back to reference Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down’s syndrome. J Med Screen. 2002;9(1):2–6. CrossRefPubMed Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down’s syndrome. J Med Screen. 2002;9(1):2–6. CrossRefPubMed
26.
go back to reference Cuckle HS, Wald NJ, Thompson SG. Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 1987;94(5):387–402. CrossRefPubMed Cuckle HS, Wald NJ, Thompson SG. Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 1987;94(5):387–402. CrossRefPubMed
27.
go back to reference Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, et al. Position statement from the aneuploidy screening committee on behalf of the board of the international society for prenatal diagnosis. Prenat Diagn. 2013;33(7):622–9. CrossRefPubMed Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, et al. Position statement from the aneuploidy screening committee on behalf of the board of the international society for prenatal diagnosis. Prenat Diagn. 2013;33(7):622–9. CrossRefPubMed
28.
go back to reference Gezondheidsraad. Wet op het bevolkingsonderzoek: niet-invasieve prenatale test bij verhoogd risico op trisomie. Publicatienr. 2013/35. Den Haag: Gezondheidsraad; 2013. Gezondheidsraad. Wet op het bevolkingsonderzoek: niet-invasieve prenatale test bij verhoogd risico op trisomie. Publicatienr. 2013/35. Den Haag: Gezondheidsraad; 2013.
29.
go back to reference Tweede Kamer. Brief van de minister van volksgezondheid, welzijn en sport. Nr. 90 Hoofddossier prenatale screening 29 323. Den Haag: Tweede Kamer; 2014. Tweede Kamer. Brief van de minister van volksgezondheid, welzijn en sport. Nr. 90 Hoofddossier prenatale screening 29 323. Den Haag: Tweede Kamer; 2014.
30.
go back to reference Martin L, Van Dulmen S, Spelten E, Jonge A de, Cock P de, Hutton E. Prenatal counseling for congenital anomaly tests: parental preferences and perceptions of midwife performance. Prenat Diagn. 2013;33(4):341–53. CrossRefPubMed Martin L, Van Dulmen S, Spelten E, Jonge A de, Cock P de, Hutton E. Prenatal counseling for congenital anomaly tests: parental preferences and perceptions of midwife performance. Prenat Diagn. 2013;33(4):341–53. CrossRefPubMed
31.
go back to reference Gitsels-van der Wal JT, Verhoeven PS, Mannien J, Martin L, Reinders HS, Spelten E, et al. Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study. BMC Pregnancy Childbirth. 2014;14:264. CrossRefPubMedPubMedCentral Gitsels-van der Wal JT, Verhoeven PS, Mannien J, Martin L, Reinders HS, Spelten E, et al. Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study. BMC Pregnancy Childbirth. 2014;14:264. CrossRefPubMedPubMedCentral
32.
go back to reference Martin I, Hutton EK, Gitsels-van der Wal JT, Spelten ER, Kuiper F, Pereboom MTR, et al. Antenatal counseling for congenital anomaly tests: an exploratory video-observational study about client-midwife communication. Midwifery. 2015;31(1):37–46. CrossRefPubMed Martin I, Hutton EK, Gitsels-van der Wal JT, Spelten ER, Kuiper F, Pereboom MTR, et al. Antenatal counseling for congenital anomaly tests: an exploratory video-observational study about client-midwife communication. Midwifery. 2015;31(1):37–46. CrossRefPubMed
33.
go back to reference Schendel RV van, Dondorp WJ, Timmermans DR, Hugte EJ van, Boer A de, Pajkrt E, et al. NIPT-based screening for Down syndrome and beyond: what do pregnant women think? Prenat Diagn. 2015;35(6):598–604. CrossRefPubMed Schendel RV van, Dondorp WJ, Timmermans DR, Hugte EJ van, Boer A de, Pajkrt E, et al. NIPT-based screening for Down syndrome and beyond: what do pregnant women think? Prenat Diagn. 2015;35(6):598–604. CrossRefPubMed
34.
go back to reference Schendel RV van, Kleinveld JH, Dondorp WJ, Pajkrt E, Timmermans DR, Holtkamp KC, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet. 2014;22(12):1345–50. CrossRefPubMedPubMedCentral Schendel RV van, Kleinveld JH, Dondorp WJ, Pajkrt E, Timmermans DR, Holtkamp KC, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet. 2014;22(12):1345–50. CrossRefPubMedPubMedCentral
35.
go back to reference Schendel RV van, Kater-Kuipers A, Vliet-Lachotzki EH van, Dondorp WJ, Cornel MC, Henneman L. What do parents of children with down syndrome think about non-invasive prenatal testing (NIPT)? J Genet Couns. 2017;26(3):522–31. CrossRefPubMed Schendel RV van, Kater-Kuipers A, Vliet-Lachotzki EH van, Dondorp WJ, Cornel MC, Henneman L. What do parents of children with down syndrome think about non-invasive prenatal testing (NIPT)? J Genet Couns. 2017;26(3):522–31. CrossRefPubMed
36.
go back to reference Crnic K, Arbona AP, Baker B, Blacher J. Mothers and fathers together: contrasts in parenting across preschool to early school age in children with developmental delays. Int Rev Res Ment Retard. 2009;37:3–30. CrossRefPubMedPubMedCentral Crnic K, Arbona AP, Baker B, Blacher J. Mothers and fathers together: contrasts in parenting across preschool to early school age in children with developmental delays. Int Rev Res Ment Retard. 2009;37:3–30. CrossRefPubMedPubMedCentral
37.
go back to reference McConnell D, Savage A. Stress and resilience among families caring for children with intellectual disability: expanding the research agenda. Curr Dev Disord Rep. 2015;2:100. CrossRef McConnell D, Savage A. Stress and resilience among families caring for children with intellectual disability: expanding the research agenda. Curr Dev Disord Rep. 2015;2:100. CrossRef
38.
go back to reference Hamlyn-Wright S, Draghi-Lorenz R, Ellis J. Locus of control fails to mediate between stress and anxiety and depression in parents of children with a developmental disorder. Autism. 2007;11:489–501. CrossRefPubMed Hamlyn-Wright S, Draghi-Lorenz R, Ellis J. Locus of control fails to mediate between stress and anxiety and depression in parents of children with a developmental disorder. Autism. 2007;11:489–501. CrossRefPubMed
39.
go back to reference Hedov G, Anneren G, Wikblad K. Swedish parents of children with Down’s syndrome. Scand J Caring Sci. 2002;16:424–30. CrossRefPubMed Hedov G, Anneren G, Wikblad K. Swedish parents of children with Down’s syndrome. Scand J Caring Sci. 2002;16:424–30. CrossRefPubMed
40.
go back to reference Skotko BG, Levine SP, Goldstein R. Having a son or daughter with Down syndrome: perspectives from mothers and fathers. Am J Med Genet A. 2011;155A(10):2335–47. Oct. CrossRefPubMedPubMedCentral Skotko BG, Levine SP, Goldstein R. Having a son or daughter with Down syndrome: perspectives from mothers and fathers. Am J Med Genet A. 2011;155A(10):2335–47. Oct. CrossRefPubMedPubMedCentral
Metagegevens
Titel
Dilemma’s rondom prenatale screening op downsyndroom
Auteurs
Neeltje M. T. H. Crombag
Linda Martin
Janneke T. Gitsels
Publicatiedatum
15-02-2018
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 2/2018
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/s12474-018-0179-6

Andere artikelen Uitgave 2/2018

Neuropraxis 2/2018 Naar de uitgave